PubMed HealthSearch

PubMed · 8767549

[Dysmenorrhea].

Abstract

Primary dysmenorrhea is very frequent in ovulating women; it can even become a disease. In some cases, but not always, it is preceded by premenstrual tensions. Secondary dysmenorrhoea should be clearly differentiated, because it is a symptom of uterine abnormalities or adnexal diseases, whereas primary dysmenorrhoea is an entity in itself. The most frequent cause of secondary dysmenorrhoea is endometriosis. Dysmenorrhea membranacea is a rare event, but should not be forgotten. Primary dysmenorrhea involves the entire organism and the psyche of the suffering woman. The problem is its cyclic repetition and everlasting painful expectation. The pathogenesis is more clarified now but nevertheless not yet completely investigated. There is evidence that under the dominating role of sexual hormones paracrine sequelae are occurring, which result in a local increase of prostaglandins. The most important factor is the rhythmic ischemic reaction due to vasoconstriction in small arteries of the uterine wall, causing excruciating pains at times. The treatment is different whether or not children are immediately desired. Oral contraception and progestogens are useful when given days before the onset of menstruation. If the ovulatory cycle should be maintained, the drugs of choice are non-steroidal antiinflammatory preparations, among them naproxen and ibuprofen the most effective. Since those drugs exert side-effects when administered over a long period of time, alternatives must be available. The most appropriate ones are ASS, magnesium, calcium antagonists or tocolytic agents. Few new approaches to further alternative therapies (neuro-stimulation) could not provide a decrease of the uterine contractility in cases of primary dysmenorrhea.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

H Ludwig. 1996. [Dysmenorrhea].. https://pubmed.ncbi.nlm.nih.gov/8767549/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Doppler echocardiographic evaluation of ventricular diastolic filling in fetuses with ductal constriction.

To assess ventricular diastolic filling in fetuses with constriction of ducts arterious, 43 fetuses of pregnant women receiving indomethacin (100 to 150 mg/day) were examined with Doppler echocardiography. Ductal constriction occurred in 21 fetuses, defined as maximal systolic velocity > 140 cm/s and diastolic flow velocity > 30 cm/s. The variables measured to assess diastolic function were peak velocity during early diastole (peak E wave), peak velocity during atrial contraction (peak A wave), and the velocity ratio (peak E/A ratio); these were compared to maximal ductal flow velocity during systole and diastole. The mitral peak E wave, peak A wave, and peak E/A ratio in fetuses with ductal constriction showed no significant difference from those in fetuses without ductal constriction. In fetuses with ductal constriction, the tricuspid A wave increased significantly without changes in the peak E wave (57 +/- 9 vs 50 +/- 6 cm/s, p < 0.01) and the peak E/A ratio was significantly lower than in fetuses without ductal constriction (0.57 +/- 0.10 vs 0.65 +/- 0.08, p < 0.05). In 9 fetuses with ductal constriction, we compared the Doppler tricuspid E wave, A wave, and E/A ratio during indomethacin administration with those after withdrawal of the drug for a mean of 24 hours. Both systolic and diastolic ductal flow velocities in the fetuses returned to normal range after discontinuation of indomethacin. The tricuspid peak A wave decreased (59 +/- 9 vs 50 +/- 11 cm/s) and the E/ A ratio increased significantly (0.56 +/- 0.07 vs 0.69 +/- 0.07) (both p < 0.01) without any significant change in peak E wave after discontinuation of indomethacin. This study suggests that ductal constriction influences Doppler patterns of right ventricular diastolic filling. These changes could be related to the increased afterload presented to the right ventricle which might affect diastolic function.

Anti-Inflammatory Agents, Non-Steroidal

Keys to managing systemic lupus erythematosus.

The keys to coping with the variability seen in SLE are accurate differentiation of active disease from past damage and consistent monitoring for new disease manifestations and medication side effects. Common clinical problems are reviewed.

Anti-Inflammatory Agents, Non-Steroidal

Therapeutic approaches to osteoarthritis.

Management is multifaceted: Palliation of pain should be accompanied by physical and occupational therapy and use of adaptive devices to improve performance. New techniques aim to interrupt disease progression and to induce biologic repair.

Anti-Inflammatory Agents, Non-Steroidal